Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma

INTRODUCTION: Glioblastoma (GBM) is identified as a lethal malignant tumor derived from the nervous system. Despite the standard clinical strategy including maximum surgical resection, temozolomide (TMZ) chemotherapy, and radiotherapy, the median survival of GBM patients remains <15 months. Accum...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:CNS Neurosci Ther
Autori principali: Alafate, Wahafu, Li, Xiaodong, Zuo, Jie, Zhang, Hua, Xiang, Jianyang, Wu, Wei, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080429/
https://ncbi.nlm.nih.gov/pubmed/32187449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13297
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi